Shifting A Paradigm: A Molecular Approach To Staging Colorectal Cancer
2/16/2011
A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research...
Active Wound Healing Can Accelerate Tumour Formation
2/15/2011
Processes that are involved in active wound healing can lead to an increased risk for basal cell carcinoma in the skin. This is the conclusion of a recent study from the Swedish medical university Karolinska Institutet, published in the journal PNAS...
Algorithm Helps Manage ALCL Worries After Breast Augmentation
2/15/2011
In the wake of a recent FDA statement linking breast implants to a rare cancer called anaplastic large cell lymphoma (ALCL), a newly updated algorithm provides plastic surgeons with guidance in managing women with breast lumps or swelling after breast augmentation...
Polaris Group (Polaris) and The Ludwig Institute for Cancer Research (LICR) announced the enrollment of the first patient in a Phase 2 clinical trial evaluating ADI-PEG 20 in the treatment of small cell lung cancer (SCLC). The trial, sponsored by LICR, is enrolling patients at Memorial Sloan-Kettering Cancer Center and Duke University Medical Center and will soon commence at St...
No Link Between Vitamin D Levels And Prostate Cancer
2/15/2011
Vitamin D levels do not affect men's chances of developing prostate cancer, according to new research published in the journal Cancer Causes and Control. In a detailed review - funded by Cancer Research UK - scientists from the University of Bristol looked at all the available evidence and found there was no link between the amount of vitamin D in men's blood and the risk of prostate cancer...
Test Your Home For Radon; Protect Your Health
2/14/2011
Do you know that winter is the perfect time to protect the health of yourself and your family from radon? Radon is the second leading cause of lung cancer in the United States, and is the leading cause of lung cancer in nonsmokers. "The Environmental Protection Agency estimates radon causes 22,000 deaths in the U.S. a year," said James L...
Combining Targeted Agents To Kill Multiple Myeloma Cells: A First From VCU Massey
2/14/2011
Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study's findings, published in the journal Blood, are the first to demonstrate the synergistic, anti-myeloma effects of this combination regimen both in vitro and in vivo...
Many Doctors Do Not Put Cancer Patients Forward For Clinical Trials
2/13/2011
A recent survey found that over 43% of surveyed doctors did not refer or enroll a patient to a clinical trial during the preceding year, scientists at the National Cancer Institute reported in the Journal of the National Cancer Institute (JNCI). Their findings add more compelling evidence that lack of doctor participation is a key factor in low clinical trial participation among cancer patients...
Cell Medica Announces First Patient Treated In Cytomegalovirus~ACE/ASPECT Clinical Trial
2/12/2011
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London...
AACR Award For Lifetime Achievement In Cancer Research For Susan Band Horwitz, Ph.D.
2/12/2011
Susan Band Horwitz, Ph.D., will receive the Eighth AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel (Taxol), which prompted the development of this drug as an important therapy for many common solid tumors, including ovarian, breast, and lung carcinomas...